INS and type 1 diabetes mellitus: Two studies [18, 19] focused on changes in the levels of hormones regulating glycemia after DPP-4 inhibitor treatment of patients with new-onset T1DM to explore the advantages of a sitagliptin and insulin combination compared with insulin monotherapy.